OP
Peatness
Guest
Covaxin - COVID-19 Vaccine (BBV152)
These are the reported side effects of Covaxin in VigiAcess. Those categories of injury expand, use the link below to search the database
Covaxin COVID-19 Vaccine
Covaxin (BBV152, iNCOVACC) is an inactivated COVID-19 vaccine produced by Bharat Biotech located in Pune, India.
www.precisionvaccinations.com
Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine
Adjuvants are formulated as part of a vaccine to boost immune responses and enhance effectiveness.
www.nih.gov
Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors - PubMed
We have identified three novel structures for inhibitors of the poly(ADP-ribose) polymerase (PARP), a nuclear enzyme activated by strand breaks in DNA and implicated in DNA repair, apoptosis, organ dysfunction or necrosis...
pubmed.ncbi.nlm.nih.gov
Propiolactone
Propiolactone | C3H4O2 | CID 2365 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.
pubchem.ncbi.nlm.nih.gov
COVAXIN - India's First Indigenous Covid-19 Vaccine | Bharat Biotech
COVAXIN, India's first indigenous COVID vaccine is developed by the corona vaccine manufacturer Bharat Biotech. It is an inactivated COVID-19 vaccine and human trials are about to commence across India.
www.bharatbiotech.com
These are the reported side effects of Covaxin in VigiAcess. Those categories of injury expand, use the link below to search the database
VigiAccess
vigiaccess.org